Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy

Overview of attention for article published in Frontiers in immunology, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

patent: 2 patents

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 39 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CD25 ANTIBODIES

Application WO-2020102591-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS FOR IN VITRO CULTIVATION AND/OR EXPANSION OF REGULATORY T CELLS

Application EP-3551749-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.